HarNeedi - Healthcare & Pharma Job Portal

Stem Cell Basics - Introduction: You may be amazed by the fact that human body is made up of approximately 35 billion of cells and these cells are categorized into approximately 200 terminally differentiated or matured cell types. These terminally differentiated or matured cell types are highly specialized, and have an ability to perform specific tasks or functions in a multicellular organism. All terminally differentiated cell types have common origin, ie from “Stem Cell”. Cells that have an ability to divide and differentiate into terminally differentiated or matured cell types and tissues are termed as Stem Cells. Stem cells differ from other cells types by two important characteristics: They are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity.  Under certain physiologic or experimental conditions, they can be induced to become tissue or organ-specific cells with special functions. Once terminally diffe

Generics Revolutionizing the Indian Healthcare Industry: The Indian pharma industry traces back its origin to 1903 when Bengal Chemical and Pharmaceutical Works was initiated in Calcutta by Professor P.C. Roy Pre?independent India largely remained dependent on other countries for medicines. The major suppliers were UK, France, and Germany. The new government post-independence focused on self-dependence and emphasized on industrialization that also included pharmaceuticals. As a result Hindustan Antibiotics Ltd. (HAL) came into existence in 1954, and following it was Indian Drugs and Pharmaceuticals Ltd. (IDPL) in 1961. The IDPL program proved India to be capable of producing drugs at very reasonable prices and also helped in developing human and physical capital, and in establishing a network of research institutes. In spite of these facts, till 1970s the pharma industry in India was dominated by multinational companies (MNCs), which continued minimum physical operations in India.

Marketing Excellence: ​Currently, product success in biopharma segment decided by company’s ability to prove satisfactory value in an accessible population. To be commercially workable, product must bring possible grounds to support the value they provide, presenting a positive balance within the clinical and non clinical does good, the financial and therapy burden costs. The information must give an apparent transcendency for a clinical requirement in contact with current choices and present this transcendency is worth the monetary value. Seriously, both of these areas are compelling recognition by both treating medical practitioners and those financing the new approach. Making out perfectly necessitates biopharma to be more accurate when getting the brands in market. It is now important to work up commercial and the right enter in to clinical development as soon as possible and constantly through the product life cycle. This can be achievable when clinical and medical exper

Heartburn, is a burning sensation in the chest (just behind the breastbone or in the epigastrium), that may radiate to the neck, throat, or angle of the jaw. The condition is medically known as pyrosis or acid indigestion, is defined as “Substernal pain or burning sensation, usually associated with regurgitation of acid-peptic gastric juice into the esophagus.” Heart burn is painful and places persons in an uncomfortable situation. Chronic heartburn damages the esophagus and it can even induce a heart disease. Signs and Symptoms may Include:​ An uncomfortable sensation of warmth or burning in the chest. Which tends to take place after eating or during sleep and it last from a few minutes to several hours. The pain gets worse (when bending over or lying down) Some patients may experience a burning sensation in the throat Sometimes there is a chronic cough, sore throat or hoarseness When swallowing, there may be a sensation of food sticking in the middle of the chest or throat

Antibiotics effects good Bacteria: Human body is made up of more than 100 trillions of cell with 210 known distinct human cell type. It is also consists of 100 trillions bacterial cells but they are 1/1000th the size of a typical human cell. Smaller in size makes bacterial cells to exist in human body. As per the research it is predicted that within 10 years, doctors would be able to treat stomach problems, asthma, and other related diseases by altering the volume of bacteria’s inside the patient body and also by killing off the harmful species of bacteria or helping the good bacteria’s to flourish inside our body. Bacteria and germs are the tiny organism that causes a disease or other problems. They are mostly found in the intestine of the human body, and help in digestion. Some bacteria also play an important role in obesity. According to Ruth Ley, a Cornell researcher, the mix of bacteria in the human gut differ dramatically depending on how much we eat and what we eat. As pe

If you’re one of those professionals who has tried assigning and experienced failure of things in a miserable manner, it’s time for them to attempt or delegation once again. That’s because failure to delegate is anguishing your professional development or career and sending the wrong signals or wrong message to your line managers. Being effete to split up or delegate the tasks or workload so that you remain efficient, fertile and originative tells the superiors that you’re not ready for taking up more challenging tasks, and may win over them you’re unable to balance or deal your time efficaciously. You may think that there is nobody for you to assist; however, that’s often just work stress. Often when you’re brim over by work you are so engaged you’ve went wrong to take a look around and identify that other professionals are ready to take this challenge or someone of your colleague (s) are delegating the same work load very smoothly, Or, you may not want to let out of assignments th

It would not be wrong to describe the drug segment in India in this condition. Naturally, the audacious faces of the drug industry may not denounce this reality. Even so, given the superfluity of regulatory warning letters and import alerts that various drug companies in the industry have obtained over the last 4 to 5 years, without doubt ,questions are confine to be placed to the companies in the drug segment. At the same time domestic business operations continuing at full strength, manufacturing for exports has taken a hit from the increased regulatory inspections by the drug authorities functionaries. One starts to wonder whether drug companies in India have been strident breakers of current good manufacturing norms. Definitely it can’t be, indeed everybody agrees. However, if the confederacy ideologues neglected, the reality stays that there are stimulating situations of abidance and making a coherent culture of quality. While the pharma stock market has witnesses major drop i

Bugs are back…? Its one of the shocking revelation of all times researchers in the healthcare sector, have expressed their concern over the new deadly strain of bacteria that is completely resistant to almost all of the known new generation antibiotics, they have said that they have run out of antibiotics that that can be used against these super bugs, these bugs are resistant to some of the most powerful antibiotics. Its the New Delhi Bacteria or New Delhi Metallo-beta-lactamase (NDM-1). Although there have only been a few cases identified and reported in the UK, USA, India, Pakistan and Bangladesh so far, but, scientists fear it will go global making it a pandemic, with newer strains making it more deadly and difficult to be treated, If so, that would be disastrous to the human race. Tight surveillance and new drugs are needed to safe guard says the researchers In the Lancet Infectious diseases paper. Research also says that the bacteria that make an enzyme called New Delhi

As India becomes more prosperous, the prevalence of diabetes is undergoing a demographic transformation, shifting from largely afflicting the affluent to increasingly burdening the poor and middle income population.according to a new study.Diabetes has long been a disease of affluence but small regional studies in recent years have indicated that, in India, it has been slowly spreading among lower income groups. However, an ongoing national survey of diabetes called the Indian Council of Medical Research – India Diabetes or simply ICMR-INDIAB study finds that many more people from middle-income and poor communities are becoming diabetic. An ongoing government funded research project to understand the prevalence pattern of diabetes across states indicates that the disease is disproportionately catching up with the urban poor in the country s developed states. The findings of  the Indian Council of Medical Research-INdia DIABetes study  is the largest national representative of di

The healthcare space is ticking with promise for technology players battling spending cuts by clients. When was the last time you actually celebrated a fever? Years ago when it helped you escape a dreaded Hindi or Maths test? For grownups too, health and its associated areas are a cause for celebration in these recession-affected times. Going by the recent Nasscom and McKinsey study titled Perspective 2020: Transform business, transform India, by 2020, 80 per cent of the industry’s incremental growth and 50 per cent of the total opportunity will come from untapped verticals such as the public sector and healthcare. The economic turmoil has impacted IT spending in key verticals such as banking, financial services and insurance, retail and manufacturing, where customers have delayed or postponed investments on deploying new technology applications. However, the IT budgets in healthcare industry are largely unaffected as service providers continue to invest in newer technologies to m

The biotech industry in Germany reached new levels of maturity when compared to the previous years, both the number of employees and the revenues generated by the sector increased markedly. Germany is home to more biotech companies than any other country in Europe. The latest figures show nearly 500 dedicated biotechnology firms in the country, over 20 of which are listed on the stock exchange. Two out of every five dedicated biotech companies in the country have secured venture capital financing, while more than a third benefit from public grants or subsidies. R&D expenditure in 2005 exceeded 700 million euros. German biotech companies have everything you need to create value on a high quality level.” Comparing business conditions for biotech companies in Germany and the United States. Germany has significantly lower operating costs.” The panelists agreed that the cost advantages in Germany are particularly noticeable for companies involved in conducting clinical trials. Accor

Are the Multi Crore corporate Hospitals making Health-care, A Costly affair for the “Aam Aadmi” in India? OR Are they bringing in cutting edge advancements in Healthcare, which were earlier beyond the reach, rather inaccessible for the Common man? OR Is it the declining state of the public healthcare system that has fueled the growth of private healthcare sector with no regulations or monitory control over the ever-growing private healthcare sector, which has made things worse for the common man? All this are matters of great debatable to justify whether the big corporate hospital groups, which have come up in the recent past, having pumped crores into infrastructure development with a touch of luxury offer services beyond the horizons of treatment and cure. Are they leverage on the declining state of the public healthcare system? Earlier Hospitals and health services segment used to be the business of some irresponsible governments which never had accountability for any lapse that

The Indian pharmaceuticals market increased at a Compound Annual Growth Rate (CAGR) of 17.46 % in 2015 from US$ 6 billion in 2005 and is expected to expand at a CAGR of 15.92 % to US$ 55 billion by 2020. In terms of world standings, the domestic pharmaceutical industry stands 4th in terms of volume and 13th in value terms. The higher-ranking in value terms could also be musing of the low prices at which medicines are sold in the country. According to the IBEF report, “By 2020, India is likely to be among the top 3 pharmaceutical markets by incremental growth and 6th largest market globally in absolute size”, also highly organized sector, a number of medicine companies promoting their operations in India. Biopharma companies have built up Good Manufacturing Practices (GMP) compliant facilities for the manufacture of different dosage forms. In addition to having GMP, WHO, several Indian companies have also been obtaining plant approvals from international regulatory agencies like US

Focusing at Productivity..! Managers have the challenges of employing, training, motivating and engaging employees, all in the view of concentrating and enhancing organization productivity and eventually profitability of organization. The process for getting higher employee productivity can be complex thing, as each employee can have different level of skill sets, interest and different level of motivations. Small business managers should ply both all-embracing and individualized programs to enhance heighten employee motivation, engagement and productivity. First Step: Work with employees to set specific job goals. The goal-setting process communicates expectations and includes employees in overall company goals. Goals should include more than   productivity measures to be most effective . Managers should help an employee set goals for training and personal growth as well as job performance. This investment in employee growth will increase job productivity by allowing the employee

The Healthcare Industry in India has become one of the largest sectors in the country in regards to employment and revenue. As Healthcare expenditure increases, so do the tax revenues for India. As the population continues to grow, the need for better Healthcare Services is also growing. Currently, 5 percent of the country’s GDP is expended on the Healthcare sector. The country’s healthcare industry has been growing exponentially in last few years, and the Health Ministry targets for the development of new technologies to end the year for treating diseases, such as tuberculosis and cancer. Recently, the passing of the most awaited Goods and Services Tax (GST) Bill caught the attention throughout all industries in India. It should benefit most sectors and make taxation easier as it replaces several different duties and taxes. Effects of GST on the Healthcare Industry: The passing of the GST (Goods and Services Tax) Bill has grabbed the attention across all the industries in the cou

Medical care gaps… Tip off for Doctors:  In today’s global clinical environment, loads from patients continually rising and physicians or medical surgeons can see many patients in a single day. While centering to see and care them all, one is also essaying to attain many outlooks – those of work life (patients and colleagues) and personal life (family and friends). However when healthcare professionals have too many expectations, these can cause to gaps among attaining with the expectations and what is really possible. Unluckily and as most of doctors would have saw the tough way, this can have patient acrimoniousness if and when anticipations aren't met. The disparity can be addressed by taking the sufficient time to concentrate on the bedrock of expectation management – an operation or a procedure that starts and ends with good communication. This article brings a few tips off reinforce how important of a good communication is before, on and after the medical treatment. P

Medical research is the basic research, applied research, or translational research carried to aid and supports the body of knowledge in the field of medicine. There are different types of medical studies. Medical research may involve performing research on public health, biochemistry, clinical research, microbiology, physiology, oncology, surgery and research on many other non-communicable diseases. Medical research can be divided into two general categories: the evaluation of new treatments for both safety and efficacy in what are termed clinical trials, and all other research that contributes to the development of new treatments. The latter is termed preclinical research if its goal is specifically to elaborate knowledge for the development of new therapeutic strategies.  A new paradigm to biomedical research  is being termed translational research, which focuses on iterative feedback loops between the basic and clinical research domains to accelerate knowledge translation from